European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended formA hearing on infringement of EP 3 ...

The United States claimed the top spot for the first time in a decade, boasting 870 billionaires, followed by China with 823 ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for ...

This aligns with a 2023 patent filing for a process enabling 5-nm production using existing deep ultraviolet lithography (DUV) tools. Such advanced chips typically require extreme ultraviolet ...

The patent application at issue in this appeal ... Further, Odyssey Logistics’ reliance on the Supreme Court’s ICC v. Brotherhood of Locomotive Engineers (1987) was inapposite, according ...

Standard essential patent (SEP) licensing and litigation continues ... We will monitor parties’ reliance on Ericsson and any ripple effects therefrom. Each of the Obama, Trump, and Biden ...

Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...

Patent No. 63,492,402 ... Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties ...

American tech giants are increasingly focusing on the humanoid robotics space, but analysts say they're at risk of falling ...

It held that the arbitral award in favour of RIL suffered from “patent illegality ... calling it a public policy violation. Reliance Industries has consistently denied allegations and claimed ...

“Our extensive patent portfolio in quantum networking ... Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend ...

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...